TACE
Clinical trials for TACE explained in plain language.
Never miss a new study
Get alerted when new TACE trials appear
Sign up with your email to follow new studies for TACE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to stop liver cancer recurrence in high-risk patients
Disease control Recruiting nowThis study tests whether combining radiation therapy with an immunotherapy drug (sintilimab) works better than a standard liver-directed treatment (TACE) at preventing liver cancer from returning after surgery. It includes 286 adults whose tumors were removed but had narrow margi…
Matched conditions: TACE
Phase: PHASE3 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 15, 2026 19:06 UTC
-
New hope for liver cancer patients: targeted chemo beads may be safer after TIPS
Disease control Recruiting nowThis study tests if a newer type of chemoembolization (DEB-TACE) is safer and works better than the standard method (cTACE) for people with liver cancer that has spread beyond the Milan criteria and who have previously had a TIPS procedure to manage complications of cirrhosis. Ab…
Matched conditions: TACE
Phase: PHASE3 • Sponsor: First Affiliated Hospital, Sun Yat-Sen University • Aim: Disease control
Last updated Jun 11, 2026 12:10 UTC